Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02014142 · ClinicalTrials.gov registry record · Phase 2
A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma
A Phase 2 study, sponsored by Mati Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 86
- Enrollment target
NCT02014142 is a Phase 2 study that has completed, run by Mati Therapeutics. The registered enrollment target is 86 participants.
The verdict
NCT02014142, a Phase 2 study, has completed, sponsored by Mati Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 86 participants
- Enrollment target
Study Summary
Determine efficacy of the latanoprost punctal plug. Effect of configuration of L-PPDS placement on efficacy will also be examined.
Interventions
- DRUG Latanoprost Punctal Plug Delivery System (L-PPDS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2013-12 |
| Est. Completion | 2016-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02014142
The ClinicalTrials.gov registry entry for NCT02014142 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mati Therapeutics, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Latanoprost Punctal Plug Delivery System (L-PPDS) is the first listed.
NCT02014142 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02014142 about?
NCT02014142 is a clinical study titled "A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma". Determine efficacy of the latanoprost punctal plug. Effect of configuration of L-PPDS placement on efficacy will also be examined.
What is the current status of trial NCT02014142?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 86 participants. The study started on 2013-12. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02014142?
The interventions under investigation include: Latanoprost Punctal Plug Delivery System (L-PPDS) (DRUG).
Who is sponsoring clinical trial NCT02014142?
This trial is sponsored by Mati Therapeutics, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.